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Abstract
The prevalence of obesity is rapidly increasing throughout the world. Correspondingly, 
anesthetic procedures in obese patients are also increasing due to both treatment of obe-
sity and other surgical problems of obese patients. Anesthesia-related complications are 
also seen in obese patients than in normal-weighted population. The importance of anes-
thetic applications in obese patients originates from physiological and pharmacokinetic 
alterations. Inhalation of these patients via mask or intubation during general anesthesia 
may be difficult or even impossible. Determination of extubation time after awakening 
from anesthesia is also a critical decision. Sleep apnea syndrome and postoperative atel-
ectasis are more common in obese patients than in normal-weighted population. Another 
vital complication that should be emphasized is thromboembolism, whose incidence and 
severity may be decreased by pharmacological and functional preventive modalities. This 
patient population has elevated risk of perioperative mortality and morbidity. Prior to 
any elective surgical procedure, an obese patient should be thoroughly evaluated to check 
medical conditions that may increase perioperative mortality risk. Since anesthesiologists 
will gradually encounter more obese patients, they need a better comprehending of the 
difficulties of obesity during anesthetic procedures and taking more preventive measures 
for their patients to avoid complications, or rendering them less traumatic, if any.
Keywords: obesity, airway management, drug dosages, perioperative management, 
postoperative analgesia
1. Introduction
Though obesity is not a newly emerging problem with its epidemic character at both public 
and individual levels, there has been recent increase in the number of successful surgical 
interventions with low likelihood of serious morbidity. Body weight of more than 50% of 
adults in the United States (US) is 20% more than the body weight regarded optimum for the 
height. The percentage of such adults has increased from 30 to 50% just in 18 years [1].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Overweight has been defined as an excess of total or expected “normal” body weight, includ-
ing all tissue components (muscle, bone, water, and fat) of body composition. In practice, the 
terms obesity and overweight are often used interchangeably to refer to excess body fat, but 
ideally an index of obesity should reflect only excess adipose tissue and be independent of 
height, body fluids, and muscle, and skeletal mass.
Body mass index (BMI) is now the standard measure for describing different categories of 
obesity. It must always be remembered that BMI is an indirect measure of obesity since it only 
considers height and weight, irrespective of the source of any additional weight. BMI is cal-
culated by dividing patient weight (kilograms, kg) by the square of their height (meters, m); 
BMI = kg/m2. An increased BMI can be present from any cause of excess weight (body build-
ing, ascites, and very large tumor) even in the absence of additional fat. The United States and 
many countries classify obesity according to BMI, as shown in Table 1 [2].
While many obesity complications that pose threat to perioperative period (e.g., airway dif-
ficulties or joint problems) may be observed by physical inspection, other complications 
such as sleep apnea, systemic and pulmonary hypertension, and diabetes mellitus should 
be comprehensively assessed by careful anamnesis, physical examination, and laboratory 
tests. Obesity itself, its complications and treatment, is also important for the anesthesiologist. 
An individual who has 30% excessive weight has a 40% increased mortality risk due to heart 
disease and a 50% increased mortality risk due to stroke. Hospital costs are also higher in 
obesity, with increased risk of perioperative morbidity and mortality [3].
Preoperative assessments make perioperative period more efficient, decrease anxiety of both 
healthcare providers and cared patients, and make patients have realistic expectations which 
BMI
<20 kg/m2 Underweight
20–25 kg/m2 Normal
26–29 kg/m2 Overweight
30–39 kg/m2 Obese
≥40 kg/m2 Morbid obese
≥50 kg/m2 Super-obese
≥60 kg/m2 Super-super obese
World Health Organization (WHO) classification: BMI
30–34.9 kg/m2 Class I
35–39.9 kg/m2 Class II
>40 kg/m2 Class III
Body mass index (BMI) = weight (kilograms, kg) divided by the square of height (meters, m); BMI = Wt (kg)/Ht (m2).
Table 1. Classification of obesity by body mass index (BMI).
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increase satisfaction from pain management and entire perioperative experience. Obesity is a 
health problem associated with many medical conditions (Table 2). Preoperative assessment 
allows for detection of possible interindividual differences in terms of physiology of airways, 
pulmonary system, cardiovascular system, metabolic system, and nervous system. Another 
benefit is the important contribution of anesthesiologists to surgeons in terms of patient’s 
psychological attitude and preparation [4].
2. Preoperative assessment
It is essential to provide a clinical setting that makes obese patients feel comfortable with 
respect to physical conditions. Outpatient setting or room should be designed according to 
overweight/obese patients. Primary physicians or surgeons of the patients should not believe 
mistakenly that they have adequate knowledge about their patients’ medical  situation. 
Comorbidities or other accompanying diseases may not frequently be well-documented. 
Preoperative assessment by anesthesiologist should include the presence of hyperglycemia 
or type 2 diabetes mellitus, hyperlipidemia, hypertension, coronary artery disease, respira-
tory problems, liver disease, and obstructive sleep apnea (OSA). As per indicated surgical 
procedure, impacts of osteoarthritis should be considered regarding positioning of patient 
especially during elective surgery [5].
An often overlooked, albeit important issue is the evaluation of medical reasons for obesity. 
Incidence of endocrine disease other than type 2 diabetes mellitus was reported as 47.4% 
among morbidly obese patients considered for bariatric surgery. Prevalence of hypothyroid-
ism, pituitary diseases, and Cushing’s syndrome is shown to be 18.1, 1.9, and 16.3%, respec-
tively. Newly established endocrine diseases are present in 16.3% of all patients [6].
Organ system
Respiratory Restrictive lung disease, asthma, obstructive sleep apnea 
(OSA), obesity hyperventilation syndrome (OHS)
Cardiovascular Hypertension, cardiomyopathy, congestive heart failure, 
coronary artery disease, peripheral vascular disease, 
thromboembolism, sudden death
Endocrine/metabolic Type 2 diabetes mellitus, Cushing’s syndrome, 
hypothyroidism, hyperlipidemia, vitamin deficiencies
Gastrointestinal Hiatal hernia, inguinal and umbilical hernia, fatty liver, 
gallbladder stones
Musculoskeletal Osteoarthritis on weight-bearing joints, low-back pain
Malignancy Breast, prostate, cervix, uterus, colorectal
Psychiatric Depression, low self-esteem
Table 2. Obesity-related medical conditions.
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Psychological tests of morbidly obese patients frequently revealed depression, social impairment, 
and loss of interest in interindividual behaviors. Physicians should be aware of the likelihood of 
the presence of psychosocial problems in obese patients during the perioperative period [7].
Routine laboratory tests indicated for obese patients are summarized in Table 3. If the obese 
patient had history of bariatric surgery such as gastric bypass or other which represents a 
potential for malabsorption, a significant protein, vitamin, iron, or calcium deficiency may be 
present. Therefore, further additional tests are required in such patients to assess metabolic 
alterations (Table 4) [8].
Anesthesiologist should question all current medication of the patient, including over-the-
counter and prescribed appetite-stimulating and weight-lowering drugs since most of these 
agents are associated with serious heart and lung problems and important morbidity and 
mortality (Table 5) [8].
2.1. Assessment and optimization of airways and pulmonary system
Factors increasing perioperative risks in obese patients in terms of airways and pulmonary system 
include airway anatomy, rapid desaturation developed during anesthesia induction  secondary 
Fasting plasma glucose
Lipid profile
Electrolytes including sodium, potassium, calcium, and phosphorus
Liver function tests including AST, ALT, total, and direct bilirubin
Renal function tests including creatinine level
Complete blood cell count
Ferritin
Vitamin B12
Thyroid stimulating hormone (TSH)
25-Hydroxy vitamin D level
Testosterone level
Electrocardiogram (ECG)
Especially in >55-year-old women and >45-year-old men who has established or suspected heart disease or at higher 
risk for heart disease
P-A chest X-ray
Especially in >60-year-old patients with established or suspected lung or heart disease
Polysomnography
Other clinically indicated additional tests, such as echocardiography
Table 3. Routine preoperative tests for obese patients.
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to reduced functional residual capacity (FRC), tendency to desaturation in supine position, need 
for induction and recovery in vertical position, tendency to sleep apnea, chronic respiratory 
insufficiency, pulmonary hypertension, predisposition to deep venous thrombosis and its conse-
quences, and need for active participation to encourage for postoperative mobilization [9].
Obesity is a common and important risk factor for obstructive sleep apnea (OSA). A near 
 two-unit increment in BMI raises the probability of OSA by fourfold. While the prevalence of 
OSA in general population is 2 and 4% in women and men, respectively, it ranges from 3 to 
25% and 40 to 78% in morbidly obese women and men, respectively. Sleep apnea in obese 
patients has usually obstructive character and originated from airway stenosis secondary to 
excessive amount of peripharyngeal adipose tissue and from reduction of upper airway mus-
cle tonus during rapid eye movement (REM) sleep. BMI, neck diameter, lung function tests 
(LFT), arterial blood gas measurement during daytime room air, and sleep-related complaints 
could not adequately predict the presence and severity of OSA in obese patients [10].
Definitive diagnosis of OSA is established by polysomnography, where following criteria should 
be fulfilled: occurrence of ≥5 apneic events (≥10 s interruption of air flow despite attempting to 
breath) or ≥15 hypopneic events (>50% reduction of air flow for ≥10 s) per hour during 7-h sleep 
test. Apneic/hypopneic index (AHI) shows the total number of apneic and/or hypopneic events 
per slept hour. The severity of OSA is directly correlated with the increase in AHI [11].
The determination of OSA in obese patients has two important implications. First, patients 
with OSA are more prone to the suppressive effects of hypnotics and opioids on airway muscle 
Test Month 6 Month 12 Month 18 Month 24 Afterwards
Complete blood count √ √ √ √ √
Biochemistry profile √ √ √ √ √
Iron √ √ √ √ √
Magnesium √ √ √ √ √
Albumin √ √ √ √
Vitamin B12 √ √ √ √ √
Vitamin D √ √ √ √
Other lipid soluble vitamins √ √ √
Parathyroid hormone √ √ √
Folate √ √ √
Bone density √ √ √
Lipid panel √
Uric acid √
Vitamin K √
Table 4. Preoperative laboratory tests recommended for patients with history of bariatric surgery.
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tonus and respiration [12]. Postoperative parenteral or neuraxial opioid use may lead to respi-
ratory complications that may result in death or potentially fatal events [13, 14]. Second, OSA 
complicates laryngoscopy and mask ventilation [15]. Moreover, oxygen stores are decreased 
due to reduced expiratory reserve volume (ERV) in obese patients [16]. Combination of these 
factors predispose to serious problems in airways.
Anamnesis is the easiest way of evaluation of OSA in the preoperative period in patients who 
did not undergo polysomnography before. Such useful data could be obtained from patient’s 
roommate or sleep partner. Anamnestic data about snoring, interruption of breathing during 
sleeping (a short-time attempt to inspire after apneic episodes and wheezy breathing or resus-
citative nasal breathing), decreased daytime performance, morning headache, and  irritability 
suggest sleep apnea. Systemic hypertension and increased neck diameter (>40–42 cm at cricoid 
cartilage level) is consistent with probable OSA diagnosis [11, 17]. Other abnormalities of OSA 
detected during physical examination include somnolence and mask airway and/or intubation 
difficulties (e.g., Mallampati class III or IV hypognathia, short thyromental distance) [12, 14, 15].
Drug Implications for anesthetic procedures (reported adverse effects)
Diethylpropion Pulmonary hypertension and psychosis.
Dexfenfluramine Associated with pulmonary hypertension and cardiac valve disease.
Fenfluramine Associated with pulmonary hypertension and cardiac valve disease.
Fluoxetine Selective serotonin reuptake inhibitor. Associated with diarrhea, nausea, headache, and 
dry mouth. Bradycardia, hemorrhage, convulsion, hyponatremia, hepatotoxicity, and 
extrapyramidal effects were reported.
Mazindol Pulmonary hypertension, atrial fibrillation, and syncope episodes were reported.
Metformin No adverse effect was reported.
Orlistat Diarrhea and reduced levels of lipid-soluble vitamins were reported.
Phentermine Association with cardiopulmonary problems could not be excluded.
Phenylpropanolamine Increases risk of hemorrhagic stroke.
Sibutramine May lead to mild increases in blood pressure and heart rate. Associated with arrhythmia 
and hypertension, which is likely to be related to cardiac arrest and stroke.
Diuretics Hypovolemia, hypokalemia.
Herbal products
Chitosan No adverse effect was reported.
Chromium No adverse effect was reported.
Ephedra Hypertension, psychiatric symptoms, autonomic dysfunction, gastrointestinal 
symptoms.
Hydroxycitric acid No adverse effect was reported.
Pyruvate Death was reported in a patient with restrictive cardiomyopathy.
Table 5. Weight lowering drugs.
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Some obese patients develop chronic daytime hypoventilation, called as obesity-hypoven-
tilation syndrome (OHS) [18]. These patients also have chronic daytime hypoxemia 
(PO
2
 < 65 mmHg), which could be easily detected by pulse oximetry at room air. Permanent 
hypercapnia ((PCO
2
 > 45 mmHg) in the absence of serious obstructive pulmonary disease is 
pathognomonic for this syndrome in obese patients. These patients usually have advanced 
obesity (BMI > 40 kg/m2) and risk of OHS is markedly increased with increasing BMI [19]. 
Majority of patients with OHS has also OSA; however OHS is not common in OSA patients. 
Those patients being at the “severe” end of OHS spectrum with cor pulmonale signs and 
symptoms are called “Pickwickian” [10, 18].
Careful determination of concomitance of obesity and OHS or COPD is important since this 
combination often leads to chronic daytime hypoxemia, which in turn causes pulmonary 
hypertension, right ventricular hypertrophy, and/or right ventricular failure. Perioperative 
morbidity and mortality rates are high in these disorders (Pickwickian), where patients need 
to undergo many tests to guide for perioperative medical optimization and postoperative 
care [10, 12, 20].
In perioperative setting, oxygenation is further diminished by reduction in muscular tonus of 
chest wall and diaphragm following general anesthesia induction and skeletal muscle relax-
ation. The net effect of this on obesity is the decrease of ERV and FRC by more than 50% and 
consequent decrease in the number of alveoli making efficient gas exchange, compared to the 
preinduction phase [21]. In addition, reduction in ERV and FRC increases predisposition to 
postoperative atelectasis and may inhibit effective clearance of secretions.
Main source of oxygen reserve during apnea is ERV. Therefore, preoxygenation is less 
effective in obese patients and the time required for hemoglobin desaturation to be reduced 
to below 90% after apnea is shortened [22]. Obese patients in relaxed condition under anes-
thesia have increased likelihood of hypoxemic complication due to “reduction in apneic 
oxygenation reserve” and difficulty of performing positive pressured mask ventilation 
[15]. In patients considered for bariatric surgery, elective awake tracheal intubation may 
be the safest approach if there are signs for difficult intubation (e.g., insufficient visualiza-
tion of posterior pharyngeal wall). Before the induction, after placing a cylinder under the 
scapula and a support to the occipital region of the patient and asking for full extension at 
atlanto-occipital joint from the patient may ease awake or conventional laryngoscopy and 
intubation [23].
A study showed that laryngoscopy was more difficult to perform in obese patients (BMI > 30 kg/
m2) compared to patients with normal BMI [24]. However, authors in another study did not 
observe any correlation between difficult intubation and BMI, though they found an associa-
tion between difficult intubation and increased neck diameter (>40–42 cm) or Mallampati 
score of III or IV [25]. This may be explained by higher probability of incidence of both 
increased neck diameter and increased Mallampati class in obese patients. Moreover, since 
obese patients have elevated gastric secretion volume and acidity in the preoperative period, 
premedication is applied by administration of cimetidine, ranitidine, citric acid, sodium 
citrate, or metoclopramide. Some investigators suggest this as an indication for awake intu-
bation [26].
Obesity and Anesthesia Management
http://dx.doi.org/10.5772/65920
79
2.2. Cardiac assessment
2.2.1. Assessment and prevention of venostasis and thromboembolism
Evaluation of venous system should be prioritized in cardiovascular assessment as implied by 
mortality data. Venous emboli entered into pulmonary circulation are important causes of pul-
monary dysfunction with a 30-day mortality of 1–2%. Majority of 30-day  perioperative mortal-
ity after bariatric surgery originates from pulmonary embolism (the number of mortality for 
this reason is ≥ 3 times more than the number of mortality due to anastomosis leakage and 
consequent sepsis) [27]. Although several agents have been used to diminish the tendency to 
thrombosis, no consensus has been established. Since low-molecular-weight heparin may limit 
options for postoperative pain management, preoperative aspirin, and following warfarin (INR 
2.0–3.0) may be considered as a reasonable choice. Use of warfarin, a vitamin K antagonist, may 
elicit some problems during the postoperative period as many patients develop malabsorption 
of lipids and lipid-soluble substances, including vitamin K after Roux-en-Y gastrojejunostomy 
(RNYG). Optimizing warfarin dosage may become difficult due to this malabsorption, where 
daily adjustments are required for at least a couple of weeks [28]. Preoperative exercise, pro-
phylaxis through antithrombotic agents and variceal socks, hematocrit count below the level of 
polycythemia, increased cardiac output, and early ambulation decrease the risk in this patient 
group. Therefore, evaluation and prophylaxis including exercise status, pharmacological treat-
ment, absence of symptoms and signs of venous disease and absence of evidence of venous 
disease, optimal hydration as well as early ambulation should be targeted [29].
2.2.2. Cardiovascular assessment
Cardiac output is expected to increase by 0.01/min for every kilogram of adipose tissue. 
Consequently, obese patients develop hypertension and associated cardiomegaly and left 
ventricular failure. To measure blood pressure accurately, an appropriate-sized cuff should 
be selected, which may not be as easy as it seems. Obesity not only leads to parenteral access 
difficulty, but also complicates noninvasive blood pressure monitoring. Direct arterial moni-
toring may be needed for accurate and continuous tracing of blood pressure and frequent 
arterial blood sampling, based on the extent of cardiopulmonary reserve [30].
Cardiac reserve may be limited in obese patients, where tolerance to hypotension, hyper-
tension, tachycardia, or volume loading-induced stress in preoperative period may be 
diminished. Most of patients with Pickwickian syndrome also have right-sided heart fail-
ure. For this reason, routine preoperative assessment should also include electrocardio-
gram (ECG) in addition to anamnesis and physical examination featuring drug treatment 
and cardiopulmonary problems (especially in terms of left or right ventricular hypertrophy, 
ischemia, and conduction defects). In cases where biventricular failure is severe and not 
 compensated with ≥2 month lasting exercises, measurement of central vascular volume when 
a large  volume of blood loss is expected related to surgery or coagulation status. Physical 
examination of peripheral venous line may also allow for planning of the possible need for 
central venous catheter. Some physicians prefer transesophageal echocardiography to assess 
central volume instead of central venous pressure (CVP) measurement [31]. There are six risk 
factors to predict perioperative cardiovascular morbidity:
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(i) High-risk surgery (e.g., emergent, major thoracic, abdominal, and vascular surgery)
(ii) History of coronary artery disease
(iii) History of congestive heart failure
(iv) History of cerebrovascular disease
(v) Preoperative insulin treatment
(vi) Preoperative plasma creatinine level >2 mg/dL
No additional cardiac tests are required for the elective surgery of patients where these risk 
factors are absent [32].
2.3. Metabolic assessment
2.3.1. Diabetes mellitus
Although 15% of patients with type I diabetes mellitus has also other comorbid autoim-
mune diseases such as Graves’ disease, Hashimoto’s thyroiditis, Addison’s disease, and 
myasthenia gravis, no such an association has been reported in terms of obesity-related 
diabetes [33].
Current treatment of type II diabetics is initiated with exercise and dietary changes usually. 
A 5–10 kg weight loss, achieved by a 20% decrease in caloric intake and elevation of daily 
physical activity to 30 min for a total of 8 weeks often normalize fasting blood glucose lev-
els. Nevertheless, this step is very difficult to achieve for most of patients, and patients will 
eventually switch to oral hypoglycemic agents, which stimulate secretion of insulin from pan-
creatic β-cells and improve insulin response of tissues by reversing postbinding defect [34]. 
Frequently used oral agents include tolazamide, tolbutamide, glyburide, and glipizide, the 
two latter being sulfonylurea class. Sulfonylureas have more long-lasting glucose-lowering 
effects (≥24 h) and lower drug-drug interaction potential [35].
By accelerating nonenzymatic glycosylation reactions, higher glucose concentrations lead to 
the formation of abnormal proteins which decrease flexibility and stretching resistance in 
wound healing, thereby causing toxic effects. Diminished flexibility may result in stiff joint 
syndrome and atlanto-occipital joint fixation which could hamper intubation [36].
Anastomosis-related infections are responsible for two-thirds of postoperative complications 
and about 20% of perioperative mortality in patients undergoing bariatric surgery and consti-
tute number one risk in this patient group. Experimental data show that multiple factors may 
increase predisposition to infection in patients with glucose intolerance. Many  alterations 
observed in leukocyte functions of hyperglycemic diabetic patients include decreased 
 chemotaxis, impaired phagocytic activity of granulocytes as well as diminished intracellu-
lar destruction of pneumococci and staphylococci [37]. Phagocytic functions of granulocytes 
improve and intracellular killing capacity become near-normal if diabetic patients are aggres-
sively treated, ensuring a blood glucose level <250 mg/dL [38].
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2.3.2. Hypocalcemia
Inadequate calcium intake is both associated with obesity and hypertension; indeed,  normalization 
of calcium intake could improve both hypertension and eating crises that lead to obesity [39].
2.3.3. Hyperlipidemia and hypolipidemia
Dietary control is an important treatment modality in all hyperlipidemia types [40]. Clofibrate 
and gemfibrozil, which are used for the management of hypertriglyceridemia, may cause 
myopathy especially in patients with hepatic or renal disease. Clofibrate may also increase 
the formation of gallbladder stones. Apart from bile acids, cholestyramine also binds to oral 
anticoagulants, digitalis class agents, and thyroid hormones. Nicotinic acid leads to periph-
eral vasodilatation, which should be likely to discontinue on the day of surgery. Probucol 
decreases synthesis of apoprotein A1. Rare malodorous perspiration and/or QT interval pro-
longation are seen during probucol usage, and sudden death in animals [41].
Hypolipidemia, albeit a rare condition, is associated with neuropathy, anemia, and renal fail-
ure. Although anesthesia experience is limited in patients with hypolipidemia, following may 
be recommended: maintenance of caloric intake and perioperative use of intravenous protein 
hydrolysates and glucose [42].
2.4. Psychological assessment and psychiatric considerations
Psychological assessment is very important for a successful outcome. Not just a week, but 
even a whole year following the surgery is not an easy period. Each patient needs to have 
increased awareness and strong-minded with a dedicated attitude of diarizing his/her diet [7]. 
Evaluations of anesthesiologist may provide important clues. Patient should be emotionally 
stable. Anesthesiologist may identify several factors about failure, which include drug abuse, 
untreated major psychiatric disorders, compulsive eating behavior, fibromyalgia, and chronic 
fatigue syndrome. Investigation, detection, and sharing of any of these may prevent potential 
frustration of surgical team and avoid patient getting stressed [43].
2.5. Musculoskeletal system assessment and other considerations for patient positioning
Several other considerations about obesity are also important for anesthesiologist in a prog-
nostic and perioperative manner. Appropriate positioning of the patient, binding of monitor-
ing devices, and performing intravenous access become complicated due to excessive and 
extensive subcutaneous fat tissue and enlarged extremities. Furthermore, assessment of blood 
pressure is also more difficult compared to normal-weighted patients (difficulty of selecting 
appropriate cuff) [44].
Assessment of positioning of obese patients prior to the surgery may abolish some postop-
erative problems. In a retrospective study, incidence of postoperative ulnar neuropathy was 
reported to be 29% in patients with BMI > 38 kg/m2, compared to 1% of the control group [45]. 
Upper brachial plexus injury may also occur secondary to excessive rotation of the head and 
cervical vertebra to the contralateral side. Hyperabduction of the arm on the affected side may 
also lead to lower nerve root injury [46].
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2.6. Risk classification
According to ASA Physical Status Classification System; patients with 30 < BMI < 40 are clas-
sified as ASA II, patients with a BMI ≥40 are classified as ASA III [47]. Also, for these patients, 
in 2007, DeMaria et al. suggested a risk stratification tool for bariatric patients. The Obesity 
Surgery-Mortality Risk Score (OS-MRS) assigns one point to each of five preoperative vari-
ables: BMI ≥ 50 kg m2, male gender, hypertension, pulmonary embolic risk factors, and 
age ≥45 years. A score of 0–1 is classified as “A,” 2–3 as “B,” and 4–5 as “C” with associated 
mortality risks of 0.2, 1.1, and 2.4%, respectively [30]. This system was later validated by a 
multicenter study of more than 4000 patients [48].
3. Intraoperative management
3.1. Positioning in morbidly obese patients
Prevalence of obesity continues to increase rapidly throughout the world [49]. Therefore, 
all anesthesiologists should be familiar with this issue not only for obesity surgery, but also 
for other types of surgery [50]. Inappropriate surgical position may lead to serious physi-
ological problems, and even physical injuries [51, 52]. On the other hand, appropriate posi-
tion may ease procedures, including especially endotracheal intubation, reduce physiological 
problems, and minimize neural and soft tissue injury [53].
Operation tables having a carrying capacity of near 400 kg should be used for safe anesthetic 
and surgical procedures in obese patients. If no special operation table is present, two stan-
dard ones having a weight-bearing capacity of 200 kg may be adjoined. Patients should be 
tightly bound to the table, ensuring supporting of areas prone to pressure by gels and pads. 
These patients may develop renal failure and potentially fatal complications at even supine 
positions [54, 55]. In a study, Bostanjian et al. [54] described six patients undergoing bariatric 
surgery, rhabdomyolysis secondary to gluteal muscle necrosis developed after supine posi-
tion, where the outcomes were fatal in three of cases.
Head-elevated laryngoscopy position, which is described as the position of head and shoul-
ders above the level of the chest, i.e., above an imaginary horizontal line joining sternal notch 
and external auditory canal, makes laryngoscopy and intubation easy [56]. The position 
where the head is lifted 25° and reverse Trendelenburg in induction anesthesia were shown to 
prolong apnea in obese patients without desaturation [57]. Functional residual capacity (FRC) 
is severely diminished in the supine position after induction of anesthesia. If the  reduction in 
FRC exceeds closure volume, small airways become also closed, ensuing a ventilation perfu-
sion disturbance [58].
Supine position: Switching from the sitting position to the supine position causes an increase 
in venous load of the heart in some patients. Reduced diaphragmatic movement by abdomi-
nal organs leads to increased respiration work, relative hypoxemia, and marked reduction in 
lung volumes [59]. Lung volume is further decreased in general anesthesia procedures where 
muscles are completely paralyzed [60]. Compared to normal-weighed patients, FRC and pul-
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monary compliance are reduced in the supine position in obese patients, eventually increas-
ing ventilation/perfusion mismatch [59]. All these alterations increase as the body mass index 
(BMI) is elevated. Induction of the anesthesia is recommended to be performed in the lateral 
decubitus position to overcome these difficulties [61]. Positive end-expiratory  pressure (PEEP) 
may improve lung functions in mechanically ventilated patients [62]. Prolonged supine 
position should be avoided in patients with reduced cardiac reserve since venous return to 
the heart is diminished by increased compression onto the inferior vena cava secondary to 
abdominal pressure and weight. In such cases, operation table or the patient may be turned to 
the side so as to decrease aortocaval compression [53, 63].
Trendelenburg position: Patient’s head is below the horizontal plane in Trendelenburg posi-
tion, which may increase operative exposure and decrease bleeding in selected cases. It is 
less tolerated than that in the supine position. In obese patients who already have limited 
cardiac reserves, blood in lower extremities is added into central and pulmonary circulation 
by Trendelenburg position, making it hard to tolerate this position [64]. It should be especially 
avoided in morbidly obese patients. Further diminished residual capacity and pulmonary 
compliance in this position also lead to atelectasis and hypoxemia. In addition, endotracheal 
tube may be displaced depending on the position. In brief, this position is often not preferred 
in obese patients due to all these factors [53, 63].
Head-upward position: Upper torso of morbidly obese patients should be nearly 35–40° in the 
sitting position or reverse Trendelenburg position in a way where the operation table allows 
for adequate ventilation. Such position simplifies mask ventilation and conditions of tracheal 
intubation.
The combined effect of reverse Trendelenburg position and pneumoperitoneum during lapa-
roscopic gastric bypass surgery decreases femoral blood flow and increases venous stasis, 
thereby increasing risk of pulmonary embolism. Therefore, prolonged applications of this 
position should be avoided with altering positions occasional breaks during surgery [65].
Prone position: Prone position was shown to increase oxygenation in normal-weighed 
patients under anesthesia than that in supine position [66]. As long as the chest and pelvis are 
supported such adequately that allows for abdominal movements, prone position is  usually 
well-tolerated by obese patients. Cardiovascular functions are preserved when appropri-
ate position and supports are provided. Otherwise, cardiac venous return is diminished by 
compression onto the inferior vena cava and femoral veins, which in turn leads to decreased 
volume in the left ventricle, causing hypotension. Prone position in obese patients under 
anesthesia improves pulmonary functions and increase FRC, pulmonary compliance, and 
oxygenation [53, 67].
Lateral decubitus position: This position is often tolerated well by obese patients. A decrease 
in the abdominal fat mass’ compression on the abdomen diminishes intraabdominal pres-
sure, which eases diaphragmatic movements during mechanical ventilation. However, main-
tenance of the same position for a long while may lead to vascular congestion and resulting in 
hypoventilation in underlying lung [68].
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Lithotomy position: This position causes increased venous return and cardiac output, and 
high risk of thromboembolism secondary to venous stasis after prolonged surgery. Another 
complication of this position may be the development of compartment syndrome when the 
lower extremities are inappropriately positioned [53, 69].
3.2. Airway management
Obesity leads to many anatomic alterations in airways. Upper thoracic and lower cervical 
fat pillows result in a limited range of motion in atlantoaxial joints and cervical vertebra. 
Excessive tissue folds in the pharynx, short and thickened neck, suprasternal, presternal, 
and posterior cervical fat tissue, and thick submental fat tissue are formed. All these altera-
tions contribute to potentially difficult airway management, which has been reported as 
10.3–20.2% in obese patients compared to 1.5–3.2% of general population [70]. Despite all 
these anatomical and pathological changes, extent of BMI did not appear to influence dif-
ficulty of laryngoscopy. This type of difficulty is rather associated with advanced age, male 
sex, temporomandibular joint pathology, Mallampati class III and IV, history of obstructive 
sleep apnea, and abnormal upper teeth [71]. Neck diameter has been defined as the best 
determinant for intubation difficulty in morbidly obese patients. While the probability of 
problematic intubation was 5% in patients with a neck diameter of 40 cm, this was found 
to be 35% in patients with a neck diameter of 60 cm [72]. Increased adipose tissue on pha-
ryngeal walls in obese patients complicates mask ventilation and intubation by leading to 
alterations in upper airway anatomy. The presence of obstructive sleep apnea is an addi-
tional pathology that increases the risk for difficult intubation, hence warranting careful 
consideration in this patient population [73].
The prevalence of aspiration is low in obese patients, though risk of aspiration-related pulmo-
nary complication is known to be increased in this group [74]. Gastroesophageal reflux that 
may cause aspiration is common in obese patients. Attention should be paid in patients with 
history of gastric band application especially in terms of aspiration [64].
Intraoperative ideal ventilation strategies are still contradictory in morbidly obese patients, 
where diminished lung and thorax compliance is particularly important. The increased 
amount of thoracic fat tissue is associated with decreased FRC that may be increased by 
elevation of upper torso though this may not provide an increment as effective as in nor-
mal-weighed  people [75]. While lung volume is not altered, respiratory load, oxygen con-
sumption, and carbon dioxide synthesis are increased following diminution of lung and 
thorax compliance, which in turn leads to decreased tolerance to respiratory stress. By caus-
ing cyclic alveolar collapse, low FRC and unchanged closure volume induce alveolar injury 
associated with mechanical ventilation [29]. These patients have predisposition for postop-
erative atelectasis. An association between the extent of atelectasis and the incidence of post-
operative ARDS was also demonstrated [76]. An adequate PEEP administration is important 
to decrease  probability of atelectasis during mechanical ventilation. In obese patients, PEEP 
provides beneficial effects both on PaO
2
 and alveolar-arterial oxygen difference, even these 
benefits were shown to be more prominent as compared to normal-weighed people [15].
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Studies showed that applications of PEEP of 10–15 cm H
2
O, lung-protective low tidal vol-
ume of 6–8 ml/kg, and pressure limit below 30 cm H
2
O proved to be beneficial to obese 
patients [77]. Combined use of recruitment maneuvers and PEEP revealed better effects on 
intraoperative oxygenation and compliance compared with PEEP use alone during obesity 
surgery or in surgical obese patients. A meta-analysis reported that pressure-controlled venti-
lation and volume-controlled ventilation did not differ in terms of outcomes [78].
3.3. Induction and maintenance
All agents used in anesthesia may also be used in obese patients. However, obesity alters 
pharmacokinetic parameters depending on the lipid solubility and tissue distribution of the 
administered anesthetic agent. Nonadipose mass is also increased in obese patients. Drug 
dosages should be adjusted by considering volume of distribution for loading dose and by 
considering clearance for maintenance dose. Obese people may highly metabolize lipophilic 
agents compared to underweight people. Pharmacokinetic studies show that weakly or inter-
mediately lipophilic drugs (e.g., vecuronium) are mainly distributed into nonadipose tissues 
and the dose needs to be calculated according to the ideal body weight. If the clearance is 
equal to or less than nonobese patients, the ideal body weight should be taken into account 
for maintenance dose. If the clearance is increased with obesity, then the total body weight 
should be considered for maintenance dose.
The ideal body weight is calculated as the sum of 49.9 and 0.89 kg for each cm above the 
height of 152.4 cm in men, and as the sum of 45.4 and 0.89 kg for each cm above the height 
of 152.4 cm in women. Agents partially distributed into the adipose tissue have variable phar-
macokinetic characteristics; they usually have prolonged and unpredictable effects due to 
altered volume of distribution and clearance rates, respectively [79].
3.4. Induction agents
3.4.1. Thiopental sodium
Thiopental sodium, a frequently used agent for the induction of general anesthesia, is rap-
idly distributed to highly perfused organs such as brain, liver, lung, intestines, kidneys, 
heart, and pancreas after bolus administration into the plasma. Reduced plasma concentra-
tion and consequent loss of its effect after a short while depends on its rapid distribution 
to peripheral tissues. High lipophilicity of thiopental increases its volume of distribution 
and elimination half-life in obese patients. Due to uptake by fatty tissues, its plasma levels 
decrease within 10 min after induction and the agent is eliminated via liver. A clearance 
rate of the drug increases twofold in obese patients compared to patients with normal 
weight. It is reported that administration of the drug according to nonfat body weight is 
more reasonable for the purposes of induction anesthesia. Nevertheless, increased cardiac 
output leads to more rapid distribution of thiopental from its effective compartment into 
the plasma, hence causing an accelerated awaking in procedures where it is administered 
as single-dose bolus [5, 11].
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3.4.2. Propofol
Although propofol has a high lipophilicity, dose adjustment should be performed according 
to the total body weight due to its high clearance [80]. Its high lipophilicity and rapid distri-
bution from plasma into peripheral tissue render it as the currently most commonly used 
induction agent in morbidly obese patients. It could be used safely as total intravenous anes-
thetic drug. Its short-acting nature after single-dose bolus administration is explained by its 
redistribution from the compartment it acts on, into the plasma and peripheral  tissues. As in 
thiopental sodium, cardiac output is also an important marker in achieving peak plasma con-
centrations of this agent. When administered as continuous infusion in obese patients, both its 
volume of distribution and clearance increases along with increased total body weight [53, 59].
3.4.3. Etomidate
Use of etomidate should be considered in patients with hemodynamic instability. Its use is 
contradictory due to increased incidence of end-organ dysfunction and in-hospital mortality 
secondary to adrenal suppressive effects in patients administered etomidate for anesthesia 
induction. Its induction dose should be adjusted by nonfat body weight due to similar phar-
macokinetic and pharmacodynamic properties to propofol and thiopental [53, 59].
3.4.4. Opioids
Opioids were quite commonly used to control sympathetic response to tracheal intubation and 
surgical stress during induction and maintenance of the anesthesia. These agents effectively 
block the response to nociceptive stimulation in the perioperative period. Increased cardiac 
output and alteration in body composition (increased fatty tissue and nonfat body weight) 
in obese patients may change pharmacokinetic properties of the opioids. Administration of 
opioids leads to upper airway obstruction, central sleep apnea, obstructive sleep apnea, ataxic 
respiration, and hypoxemia [53, 59].
Fentanyl, one of the most frequently used opioids in anesthesia, has a significantly higher 
clearance in obese patients, which exhibits a nonlinear increase with the total body weight 
[53, 59]. As fentanyl, the onset of action of sufentanyl is 3–5 min. Although it has similar 
plasma clearance, its volume of distribution and elimination half-life is increased in obese 
patients compared to normal-weighed patients [53, 59, 81].
Alfentanyl, a derivative of fentanyl, has one-tenth of the potency than that of fentanyl. It is more 
lipophilic and has lower volume of distribution than that in fentanyl. Increased cardiac output 
decreases concentration of plasma alfentanyl during early distribution phase [53, 59, 81].
Remifentanyl is an ester opioid, which is rapidly metabolized by tissue and plasma ester-
ases. Its administration by continuous infusion is widely adopted. Effects will terminate 
within 5–10 min after cessation of the infusion, which should be given adjusted to the ideal 
body weight. Administration of remifentanyl based on the total body weight in obese patients 
may cause some adverse effects such as bradycardia, hypotension, and muscle rigidity due to 
supratherapeutic plasma concentrations [53, 59, 81].
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3.5. Inhalation agents
Release of inhalation agents is increased due to high solubility in lipids and excessive fat 
tissue. Furthermore, obese patients were reported to have slow recovery from anesthesia 
because of extended release of the inhalation agent from adipose tissue [81, 82]. In fact, 
this slow recovery not only originates from accumulation in adipose tissue but also from 
increased sensitivity in central nervous system secondary to decreased blood flow in adi-
pose tissue. On the other hand, duration of recovery after procedures of 2–4 h was reported 
to be similar between obese and nonobese patients [83]. Recovery time after desflurane and 
sevoflurane, which have low lipid solubility, is also rapid in obese patients [84]. Torri et 
al. [85] compared obese and nonobese patients and reported that alveolar and inspiratory 
sevoflurane concentrations were not much changed, yet exhaling of sevoflurane from alveoli 
was slower in obese patients.
3.5.1. Isoflurane
Isoflurane is more lipophilic than sevoflurane and desflurane, therefore not commonly used 
in obese patients. Blood flow is decreased as long as the body weight increases. In clinical 
practice, impact of body mass index on uptake of isoflurane is not clinically relevant [59, 81].
3.5.2. Sevoflurane
Having low lipophilicity and solubility, sevoflurane is rapidly absorbed and eliminated com-
pared to isoflurane [59, 81].
3.5.3. Desflurane
Desflurane, due to its limited distribution in adipose tissue and least lipophilicity and solu-
bility among available inhalation agents, is recommended in obese patients. Nevertheless, 
the effect of BMI on the absorption of desflurane is not significant. Recovery and wakening 
from desflurane than that from isoflurane occur more rapidly in both obese and nonobese 
patients [59, 81].
3.6. Neuromuscular blockers
Neuromuscular blockers are polar and hydrophilic agents, so they have limited distribution 
in adipose tissue [86]. Except succinylcholine, administrating doses of neuromuscular block-
ers are usually calculated according to ideal body weight.
3.6.1. Succinylcholine
This neuromuscular blocker is a short-acting agent with a rapid onset of action. It may be pre-
ferred in obese patients in order to provide quick tracheal intubation. Pseudocholinesterase 
levels and extracellular fluid are elevated in obese patients, which determine the duration of 
action of succinylcholine and thereby warrant the need for dose adjustment with respect to 
the total body weight [87].
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3.6.2. Vecuronium
Vecuronium has a nondepolarizing aminosteroid structure and is mainly eliminated via the liver 
and gallbladder. Since its duration of action may be prolonged when its dose is calculated accord-
ing to the total body weight, the dose should be adjusted according to the ideal body weight [88].
3.6.3. Rocuronium
Being a weakly lipophilic and quaternary ammonium neuromuscular blocker, it is highly ion-
ized with a limited extracellular distribution. Induction dose of 1.2 mg/kg calculated accord-
ing to the ideal body weight provides excellent intubation settings within 60 s. Administration 
dose should be adjusted according to the ideal body weight in order to avoid prolonged drug 
metabolism [59, 87].
3.7. Reversal of neuromuscular blocking agents
Obese patients have increased risk due to upper airway collapse and use of neuromuscu-
lar blockers. Therefore, neuromuscular block should be completely reversed before tracheal 
intubation. Doses of agents reversing neuromuscular blockers should be calculated accord-
ing to the total body weight. Rapid and thorough reversal of neuromuscular block is particu-
larly important for early restoration of lung functions during early postoperative period [89].
3.7.1. Neostigmine
A delayed time to antagonize neuromuscular block by neostigmine has been reported in 
obese patients. In the study of Suzuki et al. [90], the time elapsed to make train-of-four ratio as 
0.9 increased fourfold than normal to antagonize vecuronium. Block should not be reversed 
by neostigmine under deep neuromuscular block. Recommended dose for neostigmine is 
0.04–0.08 mg/kg, whose total dose should not exceed 5 mg [89, 90].
3.7.2. Sugammadex
A modified and most potent derivative of cyclodextrin, sugammadex binds to steroidal 
muscle relaxants with high affinity. Muscle relaxants are encapsulated within lipophilic cav-
ity. Resultant inclusion complex is excreted through kidneys. Affinity of sugammadex to 
rocuronium is higher than to either pancuronium or vecuronium. It has no effect on acetyl-
choline, endogenous steroids, or other muscle relaxing agents. It is not recommended for use 
in severe renal impairment. In intermediate and deep block, dose calculation is inadequate if 
done according to the ideal body weight; therefore, the dose needs to be adjusted by the total 
body weight or ideal body weight plus 40% [89, 91].
3.8. Regional anesthesia
Regional anesthesia may be preferred to avoid potentially difficult airway control or post-
operative respiratory complications. Detection of landmarks for central blocks or peripheral 
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nerve blocks is especially very compelling in morbidly obese patients. Seventh cervical ver-
tebra or gluteal fissure may be used to identify midline for central blocks. Distribution of the 
local anesthetics is hard to estimate due to lipid infiltration into epidural space and increased 
intraabdominal pressure, in which case 75–80% of normal local anesthetic dose may suffice. 
Regional block practices are regarded as more difficult in obese patients. In a study of 2020 
supraclavicular block applications, success rate in obese patients was 94.3% compared with 
97.3% in nonobese patients, which was significantly different [92]. The prospective study 
by Nielsen et al. [93] with over 9000 regional block procedures showed that the failure rate 
was 1.62 times higher in obese patients than in nonobese patients. Block procedures may be 
safely performed under the guidance of ultrasonography in obese patients [93, 94].
4. Postoperative care
Obesity is associated with some problems also during postoperative period. The steps 
of postoperative care of an obese patient should be carefully assessed before the surgery. 
Postoperative care should aim to prevent from respiratory dysfunction, hypothermia, hemo-
dynamic instability, thromboembolism, nausea, vomiting, and pain [95, 96].
Monitoring should be continued in the recovery unit, while the patient is in sitting position 
or the head is upward at 45°. Oxygen support should be maintained until arterial oxygen 
saturation values return to preoperative levels or the patient becomes completely mobilized. 
In order to be discharged into the ward, the patient should meet routine criteria for leaving 
wakening room, no hypopnea or apnea period should occur, and preoperative arterial oxy-
gen saturation values should be reached [96].
The prevalence of myocardial infarction is higher in this group compared to nonobese popu-
lation. In addition, a new onset of atrial fibrillation may be seen during postoperative period. 
Close monitoring of these patients should be continued also after the surgery [97, 98].
Although being rare, rhabdomyolysis is a fatal complication in this patient population. 
Predisposing factors include hypotension, dehydration, immobility, and prolonged surgical 
interventions. In particular, pain in deep tissues of gluteal region should signal rhabdomyoly-
sis. Creatine kinase levels are elevated in such patients [99].
Obesity is a risk factor for thromboembolism, where prophylaxis is recommended in all surgi-
cal interventions, except minor surgery. While oral agents such as rivaroxaban and dabiga-
tran are not recommended for obese patients, low-molecular-weight heparin is recommended 
for prophylactic purposes [96, 100].
The incidence of postoperative nausea-vomiting is not increased in obese patients, albeit a 
contradictory issue [101].
An effective postoperative pain management is important to prevent pulmonary complica-
tions and provides sufficient respiratory depth. Pain management through intramuscular 
route is not recommended in obese patients. Opioid-induced upper airway obstruction and 
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respiratory depression are more likely to be seen in obese patients with obstructive sleep 
apnea. When deciding postoperative analgesia in obese patients, selecting a multimodal anal-
gesia method rather than a unimodal method will provide more effective pain control and 
avoidance of potential complications [95, 96, 102].
4.1. Intensive care
Obesity was found to be associated with increased need for mechanical ventilation and lon-
ger duration of stay with tracheostomy and at intensive care unit. No increase in mortality 
was shown.
For mechanical ventilation, 5–7 ml/kg of tidal volume calculated according to the ideal 
body weight is recommended as well as maintaining a peak inspiratory pressure below 
35 cm/H
2
O [76, 103].
If the obese patient is hemodynamically stable and gastrointestinal system is functional, 
enteral route is preferred over parenteral route for nutrition. Guideline of Society of Critical 
Care Medicine and American Society for Parental and Enteral Nutrition reports that hypo-
caloric nutrition support preserves nitrogen balance and decreases morbidity in obese 
patients [104].
“Obesity paradox” is defined as the better prognosis of obese patients after acute cardiovas-
cular decompensation despite the established role of the obesity for developing of cardio-
vascular diseases. Nevertheless, the effects of obesity on critical illness, death, or long-term 
outcomes are conflicting [105].
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